ArticleVaccines2024

Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease.

Simon Woelfel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.